Deals, Partnering

Almac Group to undertake evaluation FLEXYTE protein kinase assays for AstraZeneca

Posted on 20 January 2010

Tags: ,

During the evaluation period AstraZeneca will assess the performance of the FLEXYTE™ platform in its laboratories against specific targets of interest.

Print Friendly, PDF & Email

Leave a Reply

 

cabannerad300x150new4gif
rauconbadgejpg
e78banner300x150animgif
cpbannerad300x150new2gif
rauconbadgejpg
e78banner300x150animgif